@article{article, title  = {{Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2017}},

 month = {{1}},

 author = {{Parker CC and Coleman RE and Sartor O and Vogelzang NJ and Bottomley D and Heinrich D and Helle SI and O'Sullivan JM and Fosså SD and Chodacki A and Wiechno P et al}},

 doi = {{10.1016/j.eururo.2017.06.021}},

 volume = {{73}},

 journal = {{European Urology}},

 issue = {{3}},

 pages = {{427-435}},

 note = {{Accessed on 2025/10/10}}}